Lori A. Hoffman

Lori A. Hoffman currently serves as the Head of Business Development at Boston Oncology, focusing on licensing biologics, biosimilars, and complex generics for the Saudi Arabian and GCC markets since September 2024. Previously, Lori held various high-level positions at Piramal Critical Care, including Vice President of Alliance Management and Business Development. Additional experience includes roles such as Head of Alliance Management at Slayback Pharma, Senior Director of Alliance Management at Frontida BioPharm, and senior positions in business development and project management at companies like Sagent Pharmaceuticals and AMRI. Lori began a career in the pharmaceutical industry as a Process Support Chemist at Upjohn after earning a BS in Chemistry from the University of Wisconsin-Madison.